Literature DB >> 18506546

Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women.

Alison J Huang1, Eliseo J Pérez-Stable, Sue E Kim, Sabrina T Wong, Celia P Kaplan, Judith M E Walsh, A Yuri Iwaoka-Scott, George F Sawaya.   

Abstract

BACKGROUND: Human papillomavirus (HPV) testing is increasingly being used to determine the optimal cervical cancer screening interval in older women. Little is known about women's attitudes toward HPV testing or how these attitudes may influence medical discussions about cervical cancer screening.
METHODS: Preferences for HPV and concomitant Papanicolaou (Pap) testing were assessed through in-person interviews with diverse women aged 50 to 80 years recruited from community and university-based practices.
RESULTS: Eight hundred and sixty-five women (257 White, 87 African American, 149 Latina, and 372 Asian) were interviewed. Approximately 60% of participants wanted to be tested for HPV and another 15% would undergo testing if recommended by their physician. Among those wanting HPV testing, 94% would want more frequent than annual Pap tests if they had a positive HPV test and a normal Pap test. Two thirds of those under age 65 would be willing to switch to triennial Pap testing, and half of those aged 65 and older would be willing to discontinue Pap testing, if they had a negative HPV test and normal Pap test. Preferences for testing varied by ethnicity, age, place of birth, and cancer history.
CONCLUSIONS: The majority of older women were willing to use HPV testing to make decisions about frequency and duration of cervical cancer screening, but up to one third would want at least annual, ongoing screening regardless of HPV test results. Efforts should be made to ensure that HPV testing is used to reinforce appropriate utilization of screening tests.

Entities:  

Mesh:

Year:  2008        PMID: 18506546      PMCID: PMC2518007          DOI: 10.1007/s11606-008-0633-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  30 in total

Review 1.  A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005.

Authors:  Crystal Calloway; Cynthia M Jorgensen; Mona Saraiya; Jennifer Tsui
Journal:  J Womens Health (Larchmt)       Date:  2006-09       Impact factor: 2.681

2.  Breast and cervical cancer screening for Puerto Ricans, African Americans, and non-Hispanic whites attending inner-city family practice centers.

Authors:  Maureen F Finney; Laurene M Tumiel-Berhalter; Chester Fox; Carlos Roberto Jaén
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

Review 3.  Genital human papillomavirus infection.

Authors:  Eileen F Dunne; Lauri E Markowitz
Journal:  Clin Infect Dis       Date:  2006-07-26       Impact factor: 9.079

4.  Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.

Authors:  Jeannie Haggerty; Fred Tudiver; Judith Belle Brown; Carol Herbert; Antonio Ciampi; Remi Guibert
Journal:  Can Fam Physician       Date:  2005-12       Impact factor: 3.275

5.  Papanicolaou testing among Native American and Hispanic populations.

Authors:  Sarah Moreland; Kimberly Engelman; K Allen Greiner; Matthew S Mayo
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

6.  Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).

Authors:  Isam A Eltoum; Janie Roberson
Journal:  Cancer       Date:  2007-02-25       Impact factor: 6.860

7.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

8.  Knowledge about cervical cancer risk factors, traditional health beliefs, and Pap testing among Vietnamese American women.

Authors:  H Hoai Do; Victoria M Taylor; Nancy Burke; Yutaka Yasui; Stephen M Schwartz; J Carey Jackson
Journal:  J Immigr Minor Health       Date:  2007-04

9.  Association between cancer risk perception and screening behavior among diverse women.

Authors:  Sue E Kim; Eliseo J Pérez-Stable; Sabrina Wong; Steve Gregorich; George F Sawaya; Judith M E Walsh; Celia P Kaplan
Journal:  Arch Intern Med       Date:  2008-04-14

Review 10.  2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

View more
  7 in total

1.  Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds.

Authors:  Sabrina T Wong; Eliseo J Pérez-Stable; Sue E Kim; Steven E Gregorich; George F Sawaya; Judith M E Walsh; A Eugene Washington; Celia P Kaplan
Journal:  Patient Educ Couns       Date:  2012-01-12

2.  Acceptable and Preferred Cervical Cancer Screening Intervals Among U.S. Women.

Authors:  Crystale Purvis Cooper; Mona Saraiya; George F Sawaya
Journal:  Am J Prev Med       Date:  2015-07-02       Impact factor: 5.043

Review 3.  How does public policy impact cervical screening and vaccination strategies?

Authors:  Thomas J Herzog; Warner K Huh; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2010-11       Impact factor: 5.482

4.  Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists.

Authors:  Jillian T Henderson; Cynthia C Harper; Sarah Gutin; Mona Saraiya; Jocelyn Chapman; George F Sawaya
Journal:  Am J Obstet Gynecol       Date:  2012-11-22       Impact factor: 8.661

5.  Colorectal cancer screening: what do women from diverse ethnic groups want?

Authors:  Judith M E Walsh; Sue E Kim; George Sawaya; Celia P Kaplan; Sabrina T Wong; Steve E Gregorich; Eliseo J Pérez-Stable
Journal:  J Gen Intern Med       Date:  2012-09-12       Impact factor: 5.128

6.  Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.

Authors:  Gina S Ogilvie; Laurie W Smith; Dirk J van Niekerk; Fareeza Khurshed; Mel Krajden; Mona Saraiya; Vivek Goel; Barbara K Rimer; Sandra B Greene; Suzanne Hobbs; Andrew J Coldman; Eduardo L Franco
Journal:  Int J Cancer       Date:  2013-07-16       Impact factor: 7.396

7.  Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing.

Authors:  M Hendry; D Pasterfield; R Lewis; A Clements; S Damery; R D Neal; R Adke; D Weller; C Campbell; J Patnick; P Sasieni; C Hurt; S Wilson; C Wilkinson
Journal:  Br J Cancer       Date:  2012-06-14       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.